1,991 results
Search Results
152. Sleep restriction exacerbates cardiac dysfunction in diabetic mice by causing cardiomyocyte death and fibrosis through mitochondrial damage
153. RSK2-mediated cGAS phosphorylation induces cGAS chromatin-incorporation-mediated cell transformation and cancer cell colony growth
154. TRIM55 restricts the progression of hepatocellular carcinoma through ubiquitin-proteasome-mediated degradation of NF90
155. TMEM209 promotes hepatocellular carcinoma progression by activating the Wnt/β-catenin signaling pathway through KPNB1 stabilization
156. Polyploidy mitigates the impact of DNA damage while simultaneously bearing its burden
157. Glycolysis-mTORC1 crosstalk drives proliferation of patient-derived endometrial cancer spheroid cells with ALDH activity
158. CircMETTL3-156aa reshapes the glycolytic metabolism of macrophages to promote M1 polarization and induce cytokine storms in sHLH
159. Effective protective mechanisms of HO-1 in diabetic complications: a narrative review
160. Targeting oncogenic MAGEA6 sensitizes triple negative breast cancer to doxorubicin through its autophagy and ferroptosis by stabling AMPKα1
161. Nuclear PCGF3 inhibits the antiviral immune response by suppressing the interferon-stimulated gene
162. 4-aminopyridine attenuates inflammation and apoptosis and increases angiogenesis to promote skin regeneration following a burn injury in mice
163. CircGSK3β mediates PD-L1 transcription through miR-338-3p/PRMT5/H3K4me3 to promote breast cancer cell immune evasion and tumor progression
164. Repair and regeneration: ferroptosis in the process of remodeling and fibrosis in impaired organs
165. Aberrant activation of a miR-101–UBE2D1 axis contributes to the advanced progression and chemotherapy sensitivity in human hepatocellular carcinoma
166. TMCO1 is upregulated in breast cancer and regulates the response to pro-apoptotic agents in breast cancer cells
167. Unveiling the crucial role of ferroptosis in host resistance to streptococcus agalactiae infection
168. The critical role of Gαi3 in oral squamous cell carcinoma cell growth
169. Characterization of regulated cancer cell death pathways induced by the different modalities of non-thermal plasma treatment
170. Biological function of sialic acid and sialylation in human health and disease
171. N6-methyladenosine-modified TRIM37 augments sunitinib resistance by promoting the ubiquitin-degradation of SmARCC2 and activating the Wnt signaling pathway in renal cell carcinoma
172. Non-canonical translation in cancer: significance and therapeutic potential of non-canonical ORFs, m6A-modification, and circular RNAs
173. DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib
174. Organoid modeling meets cancers of female reproductive tract
175. Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans
176. Pyroptosis of oral keratinocyte contributes to energy metabolic reprogramming of T cells in oral lichen planus via OPA1-mediated mitochondrial fusion
177. Blockade of CD73 potentiates radiotherapy antitumor immunity and abscopal effects via STING pathway
178. Neural stem cells derived from α-synuclein-knockdown iPS cells alleviate Parkinson’s disease
179. Type 1 interferons promote Staphylococcus aureus nasal colonization by inducing phagocyte apoptosis
180. N6-methyladenosine (m6A) writer METTL5 represses the ferroptosis and antitumor immunity of gastric cancer
181. Targeting cell death in NAFLD: mechanisms and targeted therapies
182. Multifaceted mitochondrial as a novel therapeutic target in dry eye: insights and interventions
183. Methyltransferase METTL3 governs the modulation of SH3BGR expression through m6A methylation modification, imparting influence on apoptosis in the context of Down syndrome-associated cardiac development
184. Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer
185. cirSIRT5 induces ferroptosis in bladder cancer by forming a ternary complex with SYVN1/PHGDH
186. The disruption of NEAT1-miR-125b-5p-SLC1A5 cascade defines the oncogenicity and differential immune profile in head and neck squamous cell carcinoma
187. Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives
188. Tuning the B-CLL microenvironment: evidence for BAG3 protein- mediated regulation of stromal fibroblasts activity
189. Metal-polyphenol-network coated R612F nanoparticles reduce drug resistance in hepatocellular carcinoma by inhibiting stress granules
190. GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner
191. Premature senescence is regulated by crosstalk among TFEB, the autophagy lysosomal pathway and ROS derived from damaged mitochondria in NaAsO2-exposed auditory cells
192. Tert promotes cardiac regenerative repair after MI through alleviating ROS-induced DNA damage response in cardiomyocyte
193. Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1
194. UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K/AKT/mTOR/autophagic axis
195. Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
196. p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes
197. Advancements in melanoma immunotherapy: the emergence of Extracellular Vesicle Vaccines
198. MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer
199. NUP37 promotes the proliferation and invasion of glioma cells through DNMT1-mediated methylation
200. Linear polyubiquitylation of Gli protein regulates its protein stability and facilitates tumor growth in colorectal cancer
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.